Search

Sultana Marcia Zalalee

Examiner (ID: 19085, Phone: (571)270-1411 , Office: P/2614 )

Most Active Art Unit
2614
Art Unit(s)
2614, 2619, 2679, 2628
Total Applications
597
Issued Applications
417
Pending Applications
59
Abandoned Applications
136

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4214284 [patent_doc_number] => 06087162 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Transgenic plants resistant to geminivirus infection' [patent_app_type] => 1 [patent_app_number] => 8/643779 [patent_app_country] => US [patent_app_date] => 1996-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7569 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/087/06087162.pdf [firstpage_image] =>[orig_patent_app_number] => 643779 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/643779
Transgenic plants resistant to geminivirus infection May 5, 1996 Issued
Array ( [id] => 4358017 [patent_doc_number] => 06168943 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-02 [patent_title] => 'Methods for making modified recombinant vesiculoviruses' [patent_app_type] => 1 [patent_app_number] => 8/646695 [patent_app_country] => US [patent_app_date] => 1996-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 26786 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 338 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/168/06168943.pdf [firstpage_image] =>[orig_patent_app_number] => 646695 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/646695
Methods for making modified recombinant vesiculoviruses May 2, 1996 Issued
Array ( [id] => 4345019 [patent_doc_number] => 06290952 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Method of dephosphorylating an endotoxin in vivo with alkaline phosphatase' [patent_app_type] => 1 [patent_app_number] => 8/596297 [patent_app_country] => US [patent_app_date] => 1996-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 15 [patent_no_of_words] => 12189 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/290/06290952.pdf [firstpage_image] =>[orig_patent_app_number] => 596297 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/596297
Method of dephosphorylating an endotoxin in vivo with alkaline phosphatase Apr 9, 1996 Issued
08/628014 ROTAVIRUS ENTEROTOXIN NSP4 AND METHODS OF USING SAME Apr 3, 1996 Abandoned
Array ( [id] => 1541367 [patent_doc_number] => 06372206 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-16 [patent_title] => 'Orally-administered interferon-TAU compositions and methods' [patent_app_type] => B1 [patent_app_number] => 08/616904 [patent_app_country] => US [patent_app_date] => 1996-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 12689 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/372/06372206.pdf [firstpage_image] =>[orig_patent_app_number] => 08616904 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/616904
Orally-administered interferon-TAU compositions and methods Mar 14, 1996 Issued
Array ( [id] => 4067853 [patent_doc_number] => 05866791 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Modification of lignin synthesis in plants' [patent_app_type] => 1 [patent_app_number] => 8/613942 [patent_app_country] => US [patent_app_date] => 1996-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4260 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866791.pdf [firstpage_image] =>[orig_patent_app_number] => 613942 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/613942
Modification of lignin synthesis in plants Mar 12, 1996 Issued
Array ( [id] => 3879623 [patent_doc_number] => 05747648 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-05 [patent_title] => 'Modified wheat glutens and use thereof in fabrication of films' [patent_app_type] => 1 [patent_app_number] => 8/614373 [patent_app_country] => US [patent_app_date] => 1996-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3168 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/747/05747648.pdf [firstpage_image] =>[orig_patent_app_number] => 614373 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/614373
Modified wheat glutens and use thereof in fabrication of films Mar 11, 1996 Issued
Array ( [id] => 3800726 [patent_doc_number] => 05853747 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Therapeutic and dietetic uses of a brain phospholipid-based complex' [patent_app_type] => 1 [patent_app_number] => 8/617806 [patent_app_country] => US [patent_app_date] => 1996-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1963 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/853/05853747.pdf [firstpage_image] =>[orig_patent_app_number] => 617806 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/617806
Therapeutic and dietetic uses of a brain phospholipid-based complex Feb 26, 1996 Issued
Array ( [id] => 3734469 [patent_doc_number] => 05753235 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-19 [patent_title] => 'Recombinant canine herpesviruses' [patent_app_type] => 1 [patent_app_number] => 8/602010 [patent_app_country] => US [patent_app_date] => 1996-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 26076 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/753/05753235.pdf [firstpage_image] =>[orig_patent_app_number] => 602010 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/602010
Recombinant canine herpesviruses Feb 14, 1996 Issued
Array ( [id] => 3996341 [patent_doc_number] => 05919919 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Brassica sp. gene promoter highly expressed during tapetum development' [patent_app_type] => 1 [patent_app_number] => 8/595937 [patent_app_country] => US [patent_app_date] => 1996-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 5580 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919919.pdf [firstpage_image] =>[orig_patent_app_number] => 595937 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/595937
Brassica sp. gene promoter highly expressed during tapetum development Feb 5, 1996 Issued
Array ( [id] => 3821544 [patent_doc_number] => 05783194 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-21 [patent_title] => 'Homogeneous isolate of urabe mumps virus and vaccines containing the isolate' [patent_app_type] => 1 [patent_app_number] => 8/594295 [patent_app_country] => US [patent_app_date] => 1996-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8980 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/783/05783194.pdf [firstpage_image] =>[orig_patent_app_number] => 594295 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/594295
Homogeneous isolate of urabe mumps virus and vaccines containing the isolate Jan 29, 1996 Issued
Array ( [id] => 3992924 [patent_doc_number] => 05919705 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Plant virus DNA constructs and virus resistant plants comprising said constructs' [patent_app_type] => 1 [patent_app_number] => 8/553619 [patent_app_country] => US [patent_app_date] => 1995-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12380 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919705.pdf [firstpage_image] =>[orig_patent_app_number] => 553619 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/553619
Plant virus DNA constructs and virus resistant plants comprising said constructs Nov 30, 1995 Issued
Array ( [id] => 3759892 [patent_doc_number] => 05741697 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-21 [patent_title] => 'Bacteriophage of chlamydia psittaci' [patent_app_type] => 1 [patent_app_number] => 8/565386 [patent_app_country] => US [patent_app_date] => 1995-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7015 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/741/05741697.pdf [firstpage_image] =>[orig_patent_app_number] => 565386 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/565386
Bacteriophage of chlamydia psittaci Nov 29, 1995 Issued
Array ( [id] => 3772220 [patent_doc_number] => 05773599 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-30 [patent_title] => '48 kD cellular phosphoprotein CtBP' [patent_app_type] => 1 [patent_app_number] => 8/553999 [patent_app_country] => US [patent_app_date] => 1995-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 4966 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/773/05773599.pdf [firstpage_image] =>[orig_patent_app_number] => 553999 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/553999
48 kD cellular phosphoprotein CtBP Nov 5, 1995 Issued
Array ( [id] => 3950185 [patent_doc_number] => 05935570 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-10 [patent_title] => 'Synthesis of immunologic, therapeutic and prophylactic compounds by transformed clavibacter' [patent_app_type] => 1 [patent_app_number] => 8/546117 [patent_app_country] => US [patent_app_date] => 1995-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9919 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/935/05935570.pdf [firstpage_image] =>[orig_patent_app_number] => 546117 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/546117
Synthesis of immunologic, therapeutic and prophylactic compounds by transformed clavibacter Oct 19, 1995 Issued
Array ( [id] => 4196918 [patent_doc_number] => 06013514 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Haemophilus outer membrane protein' [patent_app_type] => 1 [patent_app_number] => 8/433522 [patent_app_country] => US [patent_app_date] => 1995-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 82 [patent_figures_cnt] => 18 [patent_no_of_words] => 37180 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013514.pdf [firstpage_image] =>[orig_patent_app_number] => 433522 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/433522
Haemophilus outer membrane protein Sep 11, 1995 Issued
Array ( [id] => 3936124 [patent_doc_number] => 05981258 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Composition of trans-dominant variants of viral proteins for obtaining an antiviral effect' [patent_app_type] => 1 [patent_app_number] => 8/505210 [patent_app_country] => US [patent_app_date] => 1995-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7876 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 186 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981258.pdf [firstpage_image] =>[orig_patent_app_number] => 505210 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/505210
Composition of trans-dominant variants of viral proteins for obtaining an antiviral effect Aug 13, 1995 Issued
08/509914 MILD NEWCASTLE DISEASE VIRUS VACCINE Jul 31, 1995 Abandoned
Array ( [id] => 4299718 [patent_doc_number] => 06326007 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-04 [patent_title] => 'Attenuated lentivirus vectors expressing interferon' [patent_app_type] => 1 [patent_app_number] => 8/504723 [patent_app_country] => US [patent_app_date] => 1995-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 14 [patent_no_of_words] => 13544 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/326/06326007.pdf [firstpage_image] =>[orig_patent_app_number] => 504723 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/504723
Attenuated lentivirus vectors expressing interferon Jul 19, 1995 Issued
08/472455 RECOMBINANT VACCINES TO BREAK SELF-TOLERANCE Jun 6, 1995 Abandoned
Menu